Abstract. Mitochondrial (mt)DNA mutations have been revealed to be associated with Leber's hereditary optic neuropathy (LHON). The present study conducted clinical, genetic and molecular evaluations of two Han Chinese families. A total of 4 (3 men and 1 female) out of 14 matrilineal relatives in the families exhibited visual impairment with variable severity and age of onset. The average age of onset of visual loss was 20.5 years old. Molecular analysis of the complete mitochondrial genome in these pedigrees demonstrated that the three primary mutations associated with LHON were not detected; however, the homoplasmic m.5587T>C mutation was identified, which was localized at the end of the mitochondrially encoded transfer (t)RNA alanine gene and may alter the tertiary structure of this tRNA. Subsequently, this structural alteration may result in tRNA metabolism failure. In addition, distinct sets of mtDNA polymorphisms belonging to haplogroup F1 were detected in both families tested. The findings of the present study suggested that the m.5587T>C mutation may be involved in the pathogenesis of visual impairment. In addition, the mtDNA variant m.15024G>A(p.C93H) in the mitochondrially encoded cytochrome B gene was detected in both families, which exhibited evolutionary conservation, indicating it may serve a potential modifying role in the development of visual impairment associated with m.5587T>C mutation in these families. Furthermore, other modifying factors, including nuclear modifier genes, and environmental and personal factors may also contribute to the development of LHON in subjects carrying this mutation.
Introduction
Leber's hereditary optic neuropathy (LHON) is a neurodegenerative eye disorder, which is clinically characterized by rapid, painless, bilateral central visual loss, that commonly affects young adults (1) (2) (3) (4) . The majority of cases of LHON are the result of one of three primary mutations: m.11778G>A/mitochondrially encoded NADH:ubiquinone oxidoreductase core MT-ND4, m.3460G>A/MT-ND1 or m.14484T>C/MT-ND6 (5-7), whereas the remaining 5% of cases are caused by rare mitochondrial DNA (mtDNA) mutations and/or other factors. At present, ~40 mutations (www.mitomap. org/foswiki/bin/view/MITOMAP/MutationsLHON), which mainly occur in complex I, have been associated with LHON. Therefore, mtDNA mutations are considered the molecular basis for LHON disease (5, 8) , and they often present near or at homoplasmy. However, male bias and incomplete penetrance are typical clinical characteristics of LHON, thus indicating that LHON has a complex etiology (9, 10) . Therefore, mtDNA mutations are considered insufficient to result in the phenotypic expression of LHON, and other modifying determinants, including mitochondrial haplotypes and nuclear genetic backgrounds, and environmental factors, are likely to modulate the phenotypic manifestation of LHON-associated common or rare mtDNA mutations (11) (12) (13) (14) .
LHON is the first disorder that was recognized to be maternally inherited, and is the first to have been attributed to a point mutation in mtDNA (5) . In previous investigations, besides the three primary mutations (m.11778G>A, m.3460G>A, m.14484T>C), we identified LHON-associated m.3394T>C/MT-ND1, m.3635G>A/MT-ND1, m.3866T>C/MT-ND1, m.11696G>A /M T-ND 4, m.12238T > C/M T-ND5 a nd m.14502T>C/MT-ND6 mutations (15) (16) (17) (18) (19) 
Materials and methods
Subjects and ophthalmologic examinations. As shown in Fig. 1 (13) . For detecting the m.5587T>C mutation in the MT-TA gene, PCR amplification using oligodeoxynucleotides corresponding to mtDNA at positions 5,238-6,050 was conducted. The primer pair sequences for PCR were as follows: Forward: 5'-CTA ACC GGC TTT TTG CCC-3' and reverse 5'-ACC TAG AAG GTT GCC TGG CT-3' , which were designed according to a previously described method (20) . Subsequently, this fragment was purified and analyzed as aforementioned.
Haplogroup analyses and phylogenetic analysis. The mtDNA sequences of 17 different vertebrates were used to conduct an interspecific analysis as reported previously (11) (12) (13) . The conservation index (CI) was calculated by comparing the human nucleotide variants with the other 16 vertebrates. The CI was used to indicate the percentage of species from the list of 16 different vertebrates that have the wild-type nucleotide at the same position.
The Asian mitochondrial haplogroup of these two probands were determined using online software (www.mitotool. org/genomeRSRS.html) or based on the nomenclature of mitochondrial haplogroups previously reported (21, 22) .
Results

Clinical presentation.
Clinical data for the two Chinese probands are summarized in Table I . The four individuals that were affected by LHON in the two pedigrees comprised one woman and three men. Comprehensive medical histories of the probands confirmed that they suffered from no other clinical abnormalities, including hearing dysfunction, muscular diseases, diabetes and neurological diseases. In pedigree HZL001, the proband (III-5) was first examined at the age of 17 at the Ophthalmology Clinic of Wenzhou Medical University. He started to suffer from bilateral visual loss at the age of 15; he observed a dark cloud in the center of his vision and had difficulty discerning colors, which all appeared dark grey. Visual field test detected a large centrocecal scotomata in both eyes. His visual acuity was oculus dexter, 0.02; and oculus sinister, 0.05. Fundus examination demonstrated that both of his optic discs were abnormal: Vascular tortuosity of the central retinal vessels, circumpapillary telangiectatic microangiopathy and swelling of the retinal nerve fiber layer were detected. These findings indicated that the patient exhibited the typical clinical features of LHON. In addition, his uncle (II-1) and grandmother (I-2) exhibited visual loss, as presented in Table I . In family HZL002, the proband (III-1) exhibited bilateral visual loss from the age of 6. He was diagnosed with LHON by the Ophthalmology Clinic at Beijing University of Chinese Medicine and Pharmacology (Beijing, China). The visual field test detected a large centrocecal scotomata in both eyes. His visual acuity was 0.1 in both eyes. In addition, both optic discs were abnormal, as determined by fundus examination: Vascular tortuosity of the central retinal vessels, circumpapillary telangiectatic microangiopathy and swelling of the retinal nerve fiber layer were detected. These findings indicated that the patient exhibited the typical clinical features of LHON. Conversely, none of the other six matrilineal relatives in HZL001 exhibited visual loss.
mtDNA analysis. To explore the molecular basis of visual loss in the two pedigrees, a mutational analysis of the mitochondrial genome in the two Chinese families was conducted. Initially, three well known LHON-associated mtDNA mutations (m.11778G>A, m.3460G>A and m.14484T>C) were detected by PCR amplification and restriction enzyme digestion analysis of PCR fragments derived from each proband (data not shown). The m.11778G>A, m.3460G>A and m.14484T>C mutations were not detected. Subsequently, PCR amplification of fragments spanning the entire mitochondrial genome and a DNA sequence analysis was conducted using DNA obtained from the two probands and the affected matrilineal relatives. The homoplasmic m.5587T>C mutation was detected ( Fig. 2A) . The m.5587T>C mutation refers to a T to C transition at position 5,587 in the MT-TA gene, which is localized in the end of the MT-TA gene (position 73; Fig. 2B ), and was detected in the two pedigrees evaluated in the present study. As shown in Table II , this point at position 73 in the MT-TA gene is highly conserved among all 17 organisms analyzed, with the exception of Hylobates lar. Notably, the m.5587T>C mutation has been reported to be associated with progressive unstable gait, dysarthria, hearing loss, muscle cramps and myalgia (23, 24) . Further analysis of this gene fragment sequence, demonstrated that the homoplasmic m.5587T>C mutation was detected in matrilineal relatives of the two families but not in non-matrilineal relatives (data not shown). Furthermore, none of the 376 unrelated Chinese control subjects carried the m.5587T>C mutation.
As presented in Tables II and III, (26) and Xenopus laevis (27) . The mtDNA variant m.15024G>A(p.C93H) in the MT-CYB gene exhibited evolutionary conservation among the four organisms. However, none of the other variants exhibited evolutionary conservation, suggesting that these variants may not be functionally significant. Based on the nomenclature of mitochondrial haplogroups, the mtDNA sequence variations among two Chinese probands were used to establish the haplogroup affiliation of each mtDNA (23, 24) . In the present study, the mtDNAs of the two pedigrees belonged to haplogroup F1.
Discussion
In the present study, the genetic, clinical and molecular features of two Chinese pedigrees with LHON were reported. The primary characteristic of LHON is bilateral visual loss, which was only present in the maternal lineage of the pedigrees evaluated, thus suggesting that mtDNA mutations are the molecular basis for this disorder. Sequence analysis of the complete mitochondrial genomes of these pedigrees demonstrated that the three primary mutations associated with LHON were not present; however, distinct mtDNA polymorphisms and the m.5587T>C mutation in the MT-TA gene were detected in both pedigrees. Notably, this homoplasmic mutation was only present in the maternal lineage of the pedigrees, but not in the other members of these families. Position 73 is evolutionarily conserved in the MT-TA gene. This mutation may influence the 3' end sequences of the amino acid arm of tRNA; amino acids linked affect the tRNA structure and infer structural changes. Therefore, this mutation may affect the efficiency of amino acid translation, hinder protein synthesis and induce mitochondrial dysfunction; in particular it may affect encoding of the compound enzyme that initiates mitochondrial oxidative phosphorylation required for respiratory chain and enzyme activity. In response to abnormal oxidative phosphorylation, a series of pathological alterations may be induced, including production of oxygen free radicals and a reduction in the use of nitric oxide. In addition, this mutation may have a potential modifying role in deafness by worsening m.7505T>C mutation-induced mitochondrial dysfunction (23) . Furthermore, in a previous study, a 28-year-old woman that carried this mutation presented with a 16-year history of progressive unstable gait, dysarthria, hearing loss, muscle cramps and myalgia (24) . Notably, in the present study, the presence of the m.5587T>C mutation in the two genetically different pedigrees, both influenced by visual loss, indicated that this mutation may be associated with the pathogenesis of visual loss.
In these two families, the age of onset for visual impairment ranged between 6 and 32 years old (average, 20.5 years old). Previous studies confirmed that the age of onset for visual impairment in the two pedigrees harboring the m.5587T>C mutation was similar to that in other Chinese families with LHON carrying the m.11778G>A mutation (28) (29) (30) (31) (32) . In contrast, a number of Chinese subjects carrying the m.11778G>A mutation, which exhibited profound visual loss, the affected subjects carrying the m.5587T>C mutation suffered from mild to profound visual impairment, similar to that exhibited in patients carrying m.3394T>C, m.3635G>A, m.3866T>C, m.11696G>A, m.12238T>C and m.14502T>C mutations (15) (16) (17) (18) (19) 33) . Furthermore, there is a high penetrance of visual loss in some Chinese subjects harboring the m.11778G>A mutation (28,29,31-34) ; however, the penetrance of visual impairment was very low in the two Chinese pedigrees carrying the m.5587T>C mutation. In addition, the m.5587T>C mutation was not detected in the 376 Chinese control subjects. Similar to the three common mutations, and m.3394T>C, m.33635G>A, m.3866T>C, m.11696G>A, m.12238T>C and m.14502T>C mutations (15) (16) (17) (18) (19) , the incomplete penetrance of visual loss associated with the m.5587T>C mutation, and the lack of the mutation in any of the 376 control subjects, indicated that the m.5587T>C mutation is itself insufficient to result in the clinical phenotype. These findings suggested that other modifying factors, including mitochondrial haplotype, environmental factors and nuclear background are required for the phenotypic manifestation of the m.5587T>C mutation. In particular, mitochondrial haplotypes have been reported to influence the penetrance and expressivity of visual loss associated with primary mtDNA mutations. Therefore, secondary LHON mutations, such as m.4216T>C and m.13708G>A, have been implicated to increase the penetrance of LHON-associated primary m.11778G>A or m.14484T>C mutations (35) . In addition, in a large cohort of subjects with European ancestry, the mitochondrial haplogroup J was able to affect the phenotypic manifestation of LHON-associated m.11778G>A and m.14484T>C mutations (36, 37) . Furthermore, the m.11696G>A, m.14502T>C, m.15951A>G and m.4435A>G mutations have been reported to increase LHON penetrance in Chinese subjects (28, 31, 38) . In the two pedigrees evaluated in the present study, the mtDNA variants p.C93H in the MT-CYB gene exhibited evolutionary conservation; however, other known mutations were not detected in the LHON pedigrees. This mtDNA variant may have a potential modifying role in the development of visual impairment associated with the m.5587T>C mutation in these two pedigrees.
It has been suggested that mitochondrial haplotypes may affect the penetrance and expressivity of LHON associated with the three primary mutations (m.11778G>A, m.3460G>A and m.14484T>C). In European pedigrees, mitochondrial haplogroup J may raise the risk of LHON-associated m.11778G>A or m.14484T>C mutations (14, 39) , whereas haplogroup K may aggrandize the penetrance of primary LHON-associated m.3460G>A mutation (14) . Conversely, haplogroup H may reduce the risk of LHON-associated m.11778G>A mutation (14) . In addition, the haplogroup M7b1'2 significantly increases the occurrence of LHON, whereas the haplogroup M8a has a protective effect in Chinese pedigrees (40) . In the two families analyzed in the present study, the mitochondrial genomes of the HZL001 and HZL002 pedigrees belonged to the Eastern Asian haplogroup F1. However, since data from only two families were analyzed, and due to the lack of a large data analysis, the role the mitochondrial haplotype serves in the two families cannot be fully explained. In addition, nuclear modifier genes, including the tyrosyl-tRNA synthetase 2 gene in Chinese families (11) , or environmental factors, may have an important role in the phenotypic expression of the LHON-associated m.5587T>C mutation in the two Chinese pedigrees. Thus, the results of the present study may provide novel insights into the understanding of clinical diagnosis and valuable information on the management of LHON. 
